AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2020
Mar 13, 2020
30339_dirs_2020-03-13_7e68e1fd-6eae-493b-a08e-e27caa1333dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2020-03-02
Reporting Person: MONTECALVO DAVID A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-03-02 | Common Stock | A | 373.00 | $156.49 | Acquired | 4940.42 | Direct |
Footnotes
F1: Portion of bonus paid in stock
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27